OSTX
OS Therapies Inc
Key Financials
Net Income
$-28753844
↓ 223.7%
Operating Income
$-28705701
↓ 321.3%
Total Liabilities
$11.9M
↑ 151.0%
Total Assets
$6.8M
↑ 23.5%
Shareholders' Equity
$-6095631.00
↓ 16.4%
EPS (Diluted)
$-0.98
↓ 11.4%
Operating Cash Flow
$-14238576.00
↓ 95.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 8/14/2026 | View on SEC |
| 8-K | 8/12/2026 | View on SEC |
| 8-K | 8/6/2026 | View on SEC |
| 424B5 | 8/6/2026 | View on SEC |
| 8-K | 7/29/2026 | View on SEC |
| ARS | 7/24/2026 | View on SEC |
| DEFA14A | 7/24/2026 | View on SEC |
| DEF 14A | 7/24/2026 | View on SEC |
| 3 | 7/23/2026 | View on SEC |
| D | 7/16/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | OSTX |
| Company Name | OS Therapies Inc |
| CIK | 1795091 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | NYSE |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 410-297-7793 |